Načítá se...
Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia
A recent multicentre placebo-controlled trial by Rolnick et al. has indicated that taking 150 mg aspirin daily in women at high risk of pre-eclampsia reduced the incidence of the disease from 4.3% to 1.5% in comparison with placebo. Although the findings of this study are important, a high proportio...
Uloženo v:
| Vydáno v: | Obstet Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6038012/ https://ncbi.nlm.nih.gov/pubmed/29997692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753495X18775898 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|